Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Merck invests EUR 7.6 million

Two billion tablets

“This comprises the largest single investment in the history of Merck Spittal“, says Klaus Raunegger, Managing Director of Merck in Spittal. The site has long become a showcase plant within the Merck Group of Germany. Four of the company’s eight most important brands on the global market are manufactured in Carinthia. “Over the last ten years the number of packs of medicine produced here has increased five-fold, from 14 million to 70 million. The volume of tablets manufactured in Spittal has climbed from 400 million to 1.3 billion”, Raunegger explains.  More than 90 percent of the medication is destined for export. In 2018, the “competence center” in Spittal is expected to manufacture about two billion tablets annually. The plant produces, amongst other products, various over the counter vitamin products and food supplements, nose sprays (Nasivin) and pain relief creams. The production of “Vigantoletten” (Vitamin D) is being transferred from Darmstadt to Spittal within the context of the expansion program.  Quality control also takes place at the Carinthian facility. Production volume has risen four-fold overall during the last ten years. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Location Austria

    24.09.2019, Bucharest, Romania

  • Business Location Austria

    25.09.2019, Cluj-Napoca, Romania

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

ERC Starting Grant for molecular biologist in Innsbruck

The molecular biologist Jerome Mertens received a Starting Grant of the European Research Council (ERC) for his research into understanding the molecular and cellular causes of aging, especially brain aging and molecular cell biology of Alzheimer's disease in nerve cells.

Not Only for Startups: The Business Plan as the Road Map to Success

A great idea has been born. The product the world is waiting for has been invented. Actually, nothing can seemingly go wrong. At least one would be inclined to think so. However, the best idea or invention is worthless without a business plan to successfully bring the idea down to earth. Here you will find out what you should take into consideration when drawing up a business plan.

More news All blog posts